Cargando…

Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma

BACKGROUND: Chronic comorbidities and some of the commonly-used medications are thought to affect cancer patients’ outcomes, but their relative impact on esophageal carcinoma (EC) has not been well studied. The purpose of the study was to identify the chronic comorbidities and/or commonly-used medic...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Li-Ru, Qiao, Wei, Liao, Zhong-Xing, Komaki, Ritsuko, Ho, Linus, Hofstetter, Wayne L, Lin, Steven H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359440/ https://www.ncbi.nlm.nih.gov/pubmed/25777421 http://dx.doi.org/10.1186/s12885-015-1095-2

Ejemplares similares

Long-term survival and toxicity outcomes of intensity modulated radiation therapy for the treatment of esophageal cancer: A large single-institutional cohort study
por: Shi, Anhui, et al.
Publicado: (2017)

Cancer associated macrophage-like cells and prognosis of esophageal cancer after chemoradiation therapy
por: Gironda, Daniel J., et al.
Publicado: (2020)

A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma
por: Skinner, Heath D, et al.
Publicado: (2014)

Treatment of Brain Metastasis from Lung Cancer
por: Chi, Alexander, et al.
Publicado: (2010)

Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma
por: Goense, Lucas, et al.
Publicado: (2018)

Postoperative Radiation Therapy for Non-Small Cell Lung Cancer and Thymic Malignancies
por: Gomez, Daniel R., et al.
Publicado: (2012)

Predictive Model for Overall Survival and Cancer-Specific Survival in Patients with Esophageal Adenocarcinoma
por: Huang, He, et al.
Publicado: (2021)

Rates of Overall Survival and Intracranial Control in the Magnetic Resonance Imaging Era for Patients With Limited-Stage Small Cell Lung Cancer With and Without Prophylactic Cranial Irradiation
por: Pezzi, Todd A., et al.
Publicado: (2020)

TNFRSF1B +676 T>G polymorphism predicts survival of non-Small cell lung cancer patients treated with chemoradiotherapy
por: Guan, Xiaoxiang, et al.
Publicado: (2011)

Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy
por: Guan, Xiaoxiang, et al.
Publicado: (2010)

Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer
por: Dolan, James P., et al.
Publicado: (2013)

Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer
por: Chang, Joe Y, et al.
Publicado: (2012)

FDG uptake correlates with recurrence and survival after treatment of unresectable stage III non-small cell lung cancer with high-dose proton therapy and chemotherapy
por: Xiang, Zuo-Lin, et al.
Publicado: (2012)

Common germline polymorphisms associated with breast cancer-specific survival
por: Pirie, Ailith, et al.
Publicado: (2015)

The impact of comorbidity on cancer survival: a review
por: Søgaard, Mette, et al.
Publicado: (2013)

Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using (18)F-FDG PET/CT
por: Goense, Lucas, et al.
Publicado: (2018)

Better Prognosis and Survival in Esophageal Cancer Survivors After Comorbid Second Primary Malignancies: A SEER Database-Based Study
por: Ye, Jiayue, et al.
Publicado: (2022)

Patient-specific comorbidities as prognostic variables for survival in myelofibrosis
por: Sochacki, Andrew L., et al.
Publicado: (2022)

The Potential Role of Respiratory Motion Management and Image Guidance in the Reduction of Severe Toxicities Following Stereotactic Ablative Radiation Therapy for Patients with Centrally Located Early Stage Non-Small Cell Lung Cancer or Lung Metastases
por: Chi, Alexander, et al.
Publicado: (2014)

Prevalence of comorbidities and their impact on survival among older adults with the five most common cancers in Taiwan: a population study
por: Chien, Li-Hsin, et al.
Publicado: (2023)

TGFβ1 Polymorphisms Predict Distant Metastasis–Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy
por: Yuan, Xianglin, et al.
Publicado: (2013)

Adding Erlotinib to Chemoradiation Improves Overall Survival but not Progression-Free Survival in Stage III Non-Small-Cell Lung Cancer
por: Komaki, Ritsuko, et al.
Publicado: (2015)

The Influence of Comorbidity on Health-Related Quality of Life After Esophageal Cancer Surgery
por: Backemar, Lovisa, et al.
Publicado: (2020)

Comorbid early esophageal cancer and Gongylonema pulchrum infection: a case report
por: Zhou, Qiaozhi, et al.
Publicado: (2021)

Prognostic value of the extent of lymphadenectomy for esophageal cancer-specific survival among T1 patients
por: Wang, Yang, et al.
Publicado: (2021)

Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable non-small cell lung cancer
por: Amini, Arya, et al.
Publicado: (2012)

Heart and lung doses are independent predictors of overall survival in esophageal cancer after chemoradiotherapy
por: Xu, Cai, et al.
Publicado: (2019)

Survival Impact of Delaying Postoperative Radiotherapy in Patients with Esophageal Cancer
por: Wang, Yuanyuan, et al.
Publicado: (2018)

Comprehensive Characterization of Common and Cancer-Specific Differently Expressed lncRNAs in Urologic Cancers
por: Yan, You-Ji, et al.
Publicado: (2021)

Diabetes, metformin use, and survival in esophageal cancer: a population-based cohort study
por: Wang, Qiao-Li, et al.
Publicado: (2023)

Specific DNA methylation markers in the diagnosis and prognosis of esophageal cancer
por: Li, DaPeng, et al.
Publicado: (2019)

A Nomogram for Predicting Survival in Patients With Colorectal Cancer Incorporating Cardiovascular Comorbidities
por: Wang, Hao, et al.
Publicado: (2022)

Why is renal impairment associated with poorer cancer specific survival in breast cancer patients?: a comparison with patients with other comorbidities
por: Evans, Andy, et al.
Publicado: (2020)

Surgical Management of Proximal Humerus Fractures in Patients With Common Injury-Specific Comorbidities
por: Callahan, Blake, et al.
Publicado: (2021)

Survival outcomes in esophageal cancer patients with a prior cancer
por: Pan, Deqiang, et al.
Publicado: (2021)

Impact of Comorbidities on Survival in Gastric, Colorectal, and Lung Cancer Patients
por: Morishima, Toshitaka, et al.
Publicado: (2019)

Radiotherapy for Thymic Carcinoma: Adjuvant, Inductive, and Definitive
por: Komaki, Ritsuko, et al.
Publicado: (2014)

Comorbidity, Use of Common Medications, and Risk of Early Death in Patients with Localized or Locally Advanced Prostate Cancer
por: Nieder, Carsten, et al.
Publicado: (2011)

What Would Be the Most Appropriate α/β Ratio in the Setting of Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer
por: Chi, Alexander, et al.
Publicado: (2013)

Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality
por: Jørgensen, T L, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1mlllna7dklj1tlnbtarpns0ln